Press Releases
Relmada Therapeutics to Present at the Ladenburg Thalmann 2016 Healthcare Conference
Relmada Therapeutics to Present at the 2016 Aegis Growth Conference
Relmada Therapeutics Files Amended Complaint Against Laidlaw and Its Principals, Matthew Eitner and James Ahern
Pharmaceutical Industry Leader Ronald M. Burch Joins Relmada Therapeutics Advisory Team
Relmada Therapeutics to Present at the Rodman & Renshaw 18th Annual Global Investment Conference
Relmada Therapeutics Secures First European Patent Covering LevoCap ER
Relmada Therapeutics Announces Notice of Allowance for U.S. Patent Covering d-Methadone, an NMDA Receptor Antagonist, for the Treatment of Depression
Relmada Therapeutics' d-Methadone Receives Orphan Drug Designation for Management of Postherpetic Neuralgia
Relmada Therapeutics to Present at the LD Micro Invitational Conference
Relmada Therapeutics to Present at the 5th Annual Marcum MicroCap Conference
